Caricamento...
Oncolytic virotherapy using herpes simplex virus: how far have we come?
Oncolytic virotherapy exploits the properties of human viruses to naturally cytolysis of cancer cells. The human pathogen herpes simplex virus (HSV) has proven particularly amenable for use in oncolytic virotherapy. The relative safety of HSV coupled with extensive knowledge on how HSV interacts wit...
Salvato in:
| Pubblicato in: | Oncolytic Virother |
|---|---|
| Autori principali: | , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Dove Medical Press
2015
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4918397/ https://ncbi.nlm.nih.gov/pubmed/27512683 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/OV.S66086 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|